Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Friedreich's Ataxia
Interventions
DRUG

varenicline

up to 1mg po bid for 9 weeks

DRUG

placebo

placebo matching study drug up to 1mg po bid

Trial Locations (2)

19104

The Children's Hospital of Philadelphia, Philadelphia

33612

University of South Florida, Tampa

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Friedreich's Ataxia Research Alliance

OTHER

collaborator

Pfizer

INDUSTRY

lead

University of South Florida

OTHER